Exicure (XCUR) Net Income (QoQ) (2016 - 2026)
Exicure (XCUR) Net Income (QoQ) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Exicure |
19.38 Mn |
16.77 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
36.92% |
| Dec 31, 2025 |
-18.92% |
| Sep 30, 2025 |
7.02% |
| Jun 30, 2025 |
-187.08% |
| Mar 31, 2025 |
141.92% |
| Dec 31, 2024 |
-558.20% |
| Sep 30, 2024 |
-81.83% |
| Jun 30, 2024 |
27.62% |
| Mar 31, 2024 |
44.25% |
| Dec 31, 2023 |
71.71% |
| Sep 30, 2023 |
8.81% |
| Jun 30, 2023 |
-30.79% |
| Mar 31, 2023 |
-123.96% |
| Dec 31, 2022 |
456.51% |
| Sep 30, 2022 |
30.92% |
| Jun 30, 2022 |
10.52% |
| Mar 31, 2022 |
39.62% |
| Dec 31, 2021 |
41.25% |
| Sep 30, 2021 |
-64.91% |
| Jun 30, 2021 |
-14.36% |
